Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Generic drugs in developing countries]

P Trouiller1

  • 1Centre hospitalier universitaire de Grenoble, France.

Sante (Montrouge, France)
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Generic drugs can lower health costs in developing nations, but access remains a challenge. Community financing schemes are needed, yet may create inequities in drug availability.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial.

Trials·2020
Same author

A new SFAR/APSF collaboration: Another step towards the common goal of patient safety.

Anaesthesia, critical care & pain medicine·2019
Same author

Serious adverse events and deaths linked to poor ventilator use: A report of four closed claims.

Anaesthesia, critical care & pain medicine·2018
Same author

Norepinephrine exerts an inotropic effect during the early phase of human septic shock.

British journal of anaesthesia·2018
Same author

Iatrogenic peritonitis following an incident during ablation of a pedicle screw.

Orthopaedics & traumatology, surgery & research : OTSR·2018
Same author

Description and analysis of hospital pharmacies in Madagascar.

Annales pharmaceutiques francaises·2018

Area of Science:

  • Pharmaceutical policy
  • Global health economics
  • Public health

Background:

  • Healthcare expenditure is rising in developing countries.
  • Drugs are essential for health protection, maintenance, and restoration.
  • Generic medications offer a cost-effective health solution.

Purpose of the Study:

  • To explore the role of generic drugs in reducing health costs.
  • To examine barriers to accessing essential medicines in developing countries.
  • To assess financing schemes for drug supply and their implications.

Main Methods:

  • Analysis of national health expenditure trends.
  • Review of generic drug policies and quality assurance.
  • Evaluation of community financing models for pharmaceuticals.

Related Experiment Videos

Main Results:

  • Generic drugs, when quality-assured, can significantly reduce healthcare costs.
  • Despite cost benefits, a substantial population in developing countries lacks access.
  • Community involvement in financing may lead to limited access and inequity.

Conclusions:

  • Implementing national drug action plans with quality control is crucial for generic drug effectiveness.
  • Innovative financing mechanisms are necessary to improve drug access.
  • Careful design of financing schemes is required to ensure equitable distribution and avoid further health disparities.